116 related articles for article (PubMed ID: 14856169)
1. [Permeation and excretion of PAS following ointment application].
POLEMANN G
Z Haut Geschlechtskr; 1951 Jul; 11(1):16-20. PubMed ID: 14856169
[No Abstract] [Full Text] [Related]
2. [Titration in body fluids of PAS injected locally in therapy of tuberculous adenitis].
AGHINA A; VILLEVIEILLE L
Rass Int Clin Ter; 1951 Apr; 31(8):239-43. PubMed ID: 14854243
[No Abstract] [Full Text] [Related]
3. [Importance of determination of PAS in blood and body fluids of the patient during anti-tuberculosis therapy; causes of error].
PARAF J; DESBORDES J; ZIVY P; PARAF M; PERETZ E
Therapie; 1952; 7(5):400-7. PubMed ID: 13049230
[No Abstract] [Full Text] [Related]
4. [Appearance of a reducing property in the urine of tuberculotics during PAS therapy].
MARIANI B; MESCOLINI G
Lotta Tuberc; 1951; 21(3-4):121-34. PubMed ID: 14851812
[No Abstract] [Full Text] [Related]
5. Some cases of tuberculosis cutis treated with para-aminosalicylic acid (PAS).
LINNROS B
Acta Derm Venereol; 1951; 31(2):217-8. PubMed ID: 14829181
[No Abstract] [Full Text] [Related]
6. Results of the PAS urine test (phenistix) study done in May and June, 1959.
CHAVES AD
Am Rev Respir Dis; 1960 Jan; 81():111-2. PubMed ID: 13809516
[No Abstract] [Full Text] [Related]
7. [Determination of para-aminosalicylic acid in undiluted urine. A simple method].
FROSTAD S
Nord Med; 1960 May; 63():579-81. PubMed ID: 13825418
[No Abstract] [Full Text] [Related]
8. [CHEMICAL CONTROL OF THE TREATMENT OF TUBERCULOSIS WITH PAS].
ZIGIC M
Tuberkuloza; 1963; 15():390-2. PubMed ID: 14102587
[No Abstract] [Full Text] [Related]
9. [Examination of the PAS level in cavity secretion; cavity wall permeation to PAS & PAS in secretion].
WOLFART W
Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1951; 106(2):147-52. PubMed ID: 14925044
[No Abstract] [Full Text] [Related]
10. [Resorption and excretion of PAS, with a contribution on quantitative analysis].
SCHMITZ A; WAWER J
Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1951; 105(2):178-83. PubMed ID: 14830568
[No Abstract] [Full Text] [Related]
11. [HEPARIN OINTMENT IN THE PREVENTION OF ARTIFICIAL VENOUS THROMBOSIS CAUSED BY PAS INFUSION].
HUTAS I; VASAROS M
Tuberk Tudobetegsegek; 1963 Sep; 16():267-8. PubMed ID: 14091732
[No Abstract] [Full Text] [Related]
12. [PAS therapy of skin tuberculosis].
HORACEK J
Lek List; 1951 Feb; 6(4):115-22. PubMed ID: 14805245
[No Abstract] [Full Text] [Related]
13. [Cutaneous tuberculosis and PAS].
APFFEL CA
Ann Dermatol Syphiligr (Paris); 1951; 78(2):165-7. PubMed ID: 14829860
[No Abstract] [Full Text] [Related]
14. [Effect of PAS therapy on tuberculosis of the skin].
DEME I
Orv Hetil; 1950 Aug; 91(34):1039-43. PubMed ID: 14807513
[No Abstract] [Full Text] [Related]
15. [PAS concentration in body fluids in children].
MAGGIONI G; ASSENSIO AM
Arch Ital Pediatr Pueric; 1950; 14(2):85-100. PubMed ID: 14772022
[No Abstract] [Full Text] [Related]
16. [Effects of an inhibitory substance (p-carboxybenzol-sulfo-di-N-butylamide) on the excretion of penicillin and PAS].
BRUCKSCHEN E
Medizinische; 1952 Oct; 20(41):1295-8. PubMed ID: 13001794
[No Abstract] [Full Text] [Related]
17. PARA-AMINOSALICYLIC acid (PAS) and streptomycin in pulmonary tuberculosis; comparison between 84 PAS-treated and 82 streptomycin-treated cases.
Acta Tuberc Scand; 1952; 27(3-5):157-75. PubMed ID: 13040105
[No Abstract] [Full Text] [Related]
18. [Cutaneous reactions during PAS therapy].
VIDELA CA; REY JC; RUBINSTEIN P
Rev Asoc Med Argent; 1950 Aug; 64(683-684):366-8. PubMed ID: 14808715
[No Abstract] [Full Text] [Related]
19. Para-aminosalicylic acid (PAS) in cavernous pulmonary tuberculosis; oral treatment; comparison between the effects of PAS in oral and transthoracic administration.
DIFS H
Acta Tuberc Scand; 1951; 25(2-3):128-63. PubMed ID: 14810565
[No Abstract] [Full Text] [Related]
20. [Determination of PAS in biological fluids].
BIJOS GM
Rev Quim Farm; 1951 Jul; 16(7):211. PubMed ID: 14930437
[No Abstract] [Full Text] [Related]
[Next] [New Search]
